{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:48:26Z","timestamp":1782031706329,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijrobp.2025.07.1422","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:38:11Z","timestamp":1753339091000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality Assurance of Stereotactic Irradiation and Survival of Patients With Head and Neck Cancer in the GORTEC 2014-04 \u201cOMET\u201d Randomized Phase 2 Trial"],"prefix":"10.1016","volume":"125","author":[{"given":"Pauline","family":"Maury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Sayous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Marnaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Khalladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Shan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi","family":"Vernerey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Falcoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4755-496X","authenticated-orcid":false,"given":"Juliette","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0001","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.ijrobp.2024.11.084","article-title":"Survival without quality of life deterioration in the GORTEC 2014-04 \u201cOMET\u201d randomized phase 2 trial in patients with head and neck cancer with oligometastases using stereotactic ablative radiation therapy (SABR) alone or chemotherapy and SABR","volume":"121","author":"Thariat","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110726","article-title":"Cost-minimization analysis of the GORTEC 2014-04 randomized phase II study of stereotactic ablative radiotherapy (SABR) or chemotherapy-SABR in oligometastatic head and neck cancer","volume":"204","author":"Nerich","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0003","doi-asserted-by":"crossref","first-page":"737\u2011750","DOI":"10.1007\/s00066-024-02254-2","article-title":"Dose prescription for stereotactic body radiotherapy: General and organ-specific consensus statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery","volume":"200","author":"Brunner","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13014-020-01573-9","article-title":"On the pitfalls of PTV in lung SBRT using type-B dose engine: An analysis of PTV and worst case scenario concepts for treatment plan optimization","volume":"15","author":"Leung","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0005","doi-asserted-by":"crossref","first-page":"217\u2011223","DOI":"10.1016\/j.radonc.2019.11.001","article-title":"Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU Report 91","volume":"142","author":"De Jong","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0006","doi-asserted-by":"crossref","first-page":"2996\u20113001","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0007","doi-asserted-by":"crossref","first-page":"180\u2011185","DOI":"10.1016\/j.oraloncology.2018.11.014","article-title":"Radiation therapy quality assurance in head and neck radiotherapy \u2013 Moving forward","volume":"88","author":"McDowell","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0008","doi-asserted-by":"crossref","first-page":"e29\u2011e39","DOI":"10.1016\/j.prro.2024.07.010","volume":"15","author":"Ritter","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0009","doi-asserted-by":"crossref","first-page":"1\u20119","DOI":"10.1016\/j.radonc.2022.04.020","article-title":"Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial","volume":"172","author":"Achard","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0010","doi-asserted-by":"crossref","first-page":"755\u2011762","DOI":"10.1016\/j.canrad.2021.04.005","article-title":"A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients","volume":"25","author":"Khalladi","year":"2021","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0011","doi-asserted-by":"crossref","first-page":"336\u2011344","DOI":"10.1016\/j.rpor.2020.03.002","article-title":"Plan evaluation indices: A journey of evolution","volume":"25","author":"Patel","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0012","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170393","article-title":"Evaluating which plan quality metrics are appropriate for use in lung SBRT","volume":"91","author":"Yaparpalvi","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0013","doi-asserted-by":"crossref","first-page":"26\u201133","DOI":"10.1016\/j.radonc.2020.09.038","article-title":"What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans","volume":"153","author":"Hernandez","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0014","doi-asserted-by":"crossref","first-page":"2962\u20112970","DOI":"10.1002\/cncr.26611","article-title":"Stereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease","volume":"118","author":"Salama","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0015","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hed.23434","article-title":"Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET\u2013guided neck management policy","volume":"36","author":"Adams","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0016","doi-asserted-by":"crossref","first-page":"2051\u20112058","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.102580","article-title":"Espadon, an R package for automation, exploitation and processing of DICOM files in medical physics and clinical research","volume":"109","author":"Fontbonne","year":"2023","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0018","doi-asserted-by":"crossref","first-page":"164\u2011175","DOI":"10.1016\/j.ejmp.2021.09.014","article-title":"A systematically compiled set of quantitative metrics to describe spatial characteristics of radiotherapy dose distributions and aid in treatment planning","volume":"90","author":"Kaplan","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0019","doi-asserted-by":"crossref","first-page":"1231\u20111239","DOI":"10.1016\/0360-3016(93)90548-A","article-title":"Radiation Therapy Oncology Group: Radiosurgery quality assurance guidelines","volume":"27","author":"Shaw","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0020","doi-asserted-by":"crossref","first-page":"e18\u2011e28","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0021","doi-asserted-by":"crossref","first-page":"45\u201155","DOI":"10.1016\/S2468-1253(23)00316-3","article-title":"Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): An open-label, randomised, phase 2 trial","volume":"9","author":"Liu","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0022","doi-asserted-by":"crossref","first-page":"1732\u20111739","DOI":"10.1016\/S1470-2045(21)00528-3","article-title":"Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: A single-arm, single-centre, feasibility, phase 2 trial","volume":"22","author":"Tang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0023","doi-asserted-by":"crossref","first-page":"98\u2011106","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: A prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0024","doi-asserted-by":"crossref","first-page":"1672\u20111682","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0025","doi-asserted-by":"crossref","first-page":"e193\u2011e204","DOI":"10.1016\/S1470-2045(24)00023-8","article-title":"Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-A European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology","volume":"25","author":"Marvaso","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0026","doi-asserted-by":"crossref","first-page":"e331\u2011e343","DOI":"10.1016\/S1470-2045(23)00286-3","article-title":"Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: A consensus recommendation from the EORTC Imaging and Breast Cancer Groups","volume":"24","author":"Pasquier","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0027","doi-asserted-by":"crossref","first-page":"e121\u2011e132","DOI":"10.1016\/S1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: Systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0028","doi-asserted-by":"crossref","first-page":"e534\u2011e545","DOI":"10.1016\/S1470-2045(18)30571-0","article-title":"Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: A consensus recommendation from the EORTC Imaging Group","volume":"19","author":"Lecouvet","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110875","article-title":"Clinical impact of radiotherapy quality assurance results in contemporary cancer trials: A systematic review and meta-analysis","volume":"207","author":"Jomy","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1422_bib0030","doi-asserted-by":"crossref","first-page":"150\u2011156","DOI":"10.1016\/j.radonc.2011.05.073","article-title":"Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting","volume":"100","author":"Weber","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625060195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625060195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:30:50Z","timestamp":1782030650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625060195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0360301625060195"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.07.1422","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality Assurance of Stereotactic Irradiation and Survival of Patients With Head and Neck Cancer in the GORTEC 2014-04 \u201cOMET\u201d Randomized Phase 2 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.07.1422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}